01 Procurement
Tender overview
- Buyer
- NHS England
- Status
- Complete
- Procurement method
- Open procedure
- Category
- goods
- CPV classification
- Not supplied
- Tender period
- Not supplied — 6 February 2026
Description
Project title: NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives commencing 1st April 2026 Offer reference number: CM/TNS/25/5737 Period of framework: 1 April 2026 to 31 March 2028 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.
This page represents one OCDS contracting process. Notices can be revised over time. Values may be estimates, award values or contract values and should be read with their displayed stage and date.
02 Awards and contracts
Published award records
NHS England procurement for the supply of pangenotypic Hepatitis C treatments and the provision of Hepatitis C elimination initiatives
- Awarded
- 25 February 2026
- Award value
- £160,000,000
- Suppliers
- 2
- Signed contract
- 11 March 2026
03 Organisations
Buyers, suppliers and other parties
NHS England
Wellington House, 133-135 Waterloo Rd, London, UKI45, SE1 8UG, United Kingdom
GB-PPON PDPT-3135-BWWYAbbvie Ltd
Abbvie House Vanwall Business Park, Maidenhead, UKJ11, SL6 4UB, United Kingdom
GB-PPON PHRQ-1133-WGCHGilead Sciences Limited
280 High Holborn, London, UKI31, WC1V 7EE, United Kingdom
GB-PPON PPDW-8775-RCQVCompanies House links appear only for explicit GB-COH identifiers. BritDB does not create company links from a similar name or address.
04 Provenance
Source for this process
Contains public sector information licensed under the Open Government Licence v3.0. Official external links are available only on the source transition page.